Timing and severity of inhibitor development in recombinant versus plasma‐derived factor VIII concentrates: a SIPPET analysis

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 16, Iss. 1, 2018-01 ,pp. : 39-43

John Wiley & Sons Inc

Access to resources Recommend Favorite

Allergic reaction in a cohort of haemophilia A patients using plasma‐derived factor VIII (FVIII) concentrate is rare and not necessarily triggered by FVIII

By  

HAEMOPHILIA, Vol. 21, Iss. 4, 2015-07 ,pp. : e281-e285

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics of plasma‐derived C1‐esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study

By  

TRANSFUSION, Vol. 54, Iss. 6, 2014-06 ,pp. : 1552-1561

John Wiley & Sons Inc

Access to resources Recommend Favorite

Study of plasma‐derived miRNAs mimic differences in Huntington's disease brain

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 14, 2015-12 ,pp. : 1961-1964

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prospective, observational study of plasma‐derived factor VIII/von Willebrand factor in immune tolerance induction: the PRISM registry

By  

HAEMOPHILIA, Vol. 21, Iss. 2, 2015-03 ,pp. : e122-e124

John Wiley & Sons Inc

Access to resources Recommend Favorite